PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $2,035,000 | +56.7% | 2,278,552 | 0.0% | 0.35% | +32.6% |
Q4 2016 | $1,299,000 | -43.0% | 2,278,552 | 0.0% | 0.26% | -39.2% |
Q3 2016 | $2,278,000 | -51.6% | 2,278,552 | +6.0% | 0.43% | -57.2% |
Q2 2016 | $4,708,000 | -1.8% | 2,149,913 | 0.0% | 1.00% | -15.4% |
Q1 2016 | $4,794,000 | +47.9% | 2,149,913 | +16.1% | 1.19% | +114.5% |
Q4 2015 | $3,242,000 | +90.7% | 1,852,353 | +99.4% | 0.55% | +61.2% |
Q3 2015 | $1,700,000 | -73.5% | 928,760 | -60.6% | 0.34% | -68.9% |
Q3 2013 | $6,412,000 | +23.1% | 2,357,327 | 0.0% | 1.10% | +9.1% |
Q2 2013 | $5,210,000 | – | 2,357,327 | – | 1.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Street Partners, LLC | 1,707,764 | $9,819,643,000 | 9.95% |
SOPHROSYNE CAPITAL LLC | 951,362 | $5,472,000 | 5.57% |
GREAT POINT PARTNERS LLC | 1,694,256 | $9,742,000 | 4.33% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 436,148 | $2,508,000 | 2.19% |
AVALON CAPITAL MANAGEMENT | 110,837 | $637,000 | 0.53% |
Visium Asset Management, LP | 4,350,000 | $25,013,000 | 0.39% |
Cheyne Capital Management (UK) LLP | 25,000 | $144,000 | 0.17% |
Gruss Capital Management LP | 600,000 | $3,450,000 | 0.17% |
Capital Impact Advisors, LLC | 31,206 | $179,000 | 0.14% |
TFS CAPITAL LLC | 292,036 | $1,679,000 | 0.13% |